Fixed Income ChannelOmicron Variant Uncertainty Stresses the Importance of BondsBy Ben HernandezDecember 1, 2021
ETF Building Blocks ChannelPfizer Vaccine Should Work Against Omicron, Just Less EfficientlyBy Karrie GordonNovember 30, 2021
Leveraged & Inverse ChannelTech Strength Could Re-Assert Itself Amid New COVID VariantBy Ben HernandezNovember 30, 2021
Leveraged & Inverse ChannelMarket Swings From Omicron Variant Could Sway These Two ETFsBy Ben HernandezNovember 29, 2021
Crypto ChannelNew COVID Variant Pushes Cryptocurrencies Lower Post-ThanksgivingBy Ben HernandezNovember 29, 2021
Gold & Silver Investing ChannelRenewed Uncertainty Amid COVID Variant Pushes Gold HigherBy Ben HernandezNovember 29, 2021
Nasdaq Portfolio Solutions ChannelPfizer’s COVID-19 Pill 89% Effective in Those With Positive DiagnosisBy Karrie GordonNovember 5, 2021
China Insights ChannelChina Calls for Global Cooperation, Pledges 2 Billion Covid-19 VaccinesBy Karrie GordonAugust 13, 2021
Nasdaq Portfolio Solutions Channel‘QQQA’ Won’t Miss Its Shot as Pfizer and Moderna Set to Profit with BoostersBy Karrie GordonAugust 13, 2021
Leveraged & Inverse ChannelAccess a Recovering European Economy with the EURL ETFBy Ben HernandezApril 19, 2021
Thematic Investing ChannelWith COVID Still Front and Center, WFH Stocks and ‘CLOU’ Keep ClimbingBy Ben HernandezApril 15, 2021
